Spinal Modulation
Medical device company developing spinal cord neurostimulator systems for the treatment of chronic intractable pain.
Launch date
Market cap
-
Enterprise valuation
€164—245m (Dealroom.co estimates Jun 2013.)
Menlo Park California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$27.4m | Series C | ||
$30.0m | Series D | ||
N/A | $1.9m | Debt | |
$45.0m | Series E | ||
N/A | Acquisition | ||
Total Funding | €99.5m |